Education
About Us
Working with TipRanks
Follow Us
Botanix Pharmaceuticals Limited (AU:BOT)
ASX:BOT
Total Valuation
Botanix Pharmaceuticals Limited has a market cap or net worth of AU$285.75M. The enterprise value is AU$562.64M.
Market CapAU$285.75M
Enterprise ValueAU$562.64M
Share Statistics
Botanix Pharmaceuticals Limited has 1,970,660,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,970,660,000
Owned by Insiders1.34%
Owned by Institutions―
Financial Efficiency
Botanix Pharmaceuticals Limited’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -70.99%.
Return on Equity (ROE)-1.06
Return on Assets (ROA)-0.67
Return on Invested Capital (ROIC)-70.99%
Return on Capital Employed (ROCE)-0.78
Revenue Per Employee526.29K
Profits Per Employee-7.85M
Employee Count11
Asset Turnover0.04
Inventory Turnover0.13
Valuation Ratios
The current PE Ratio of Botanix Pharmaceuticals Limited is ―. Botanix Pharmaceuticals Limited’s PEG ratio is -0.02.
PE Ratio―
PS Ratio101.98
PB Ratio7.26
Price to Fair Value7.26
Price to FCF-7.49
Price to Operating Cash Flow-3.93
PEG Ratio-0.02
Income Statement
In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 5.79M and earned -86.40M in profits. Earnings per share was -0.05.
Revenue5.79M
Gross Profit2.02M
Operating Income-80.79M
Pretax Income-86.40M
Net Income-86.40M
EBITDA-80.65M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -78.58M and capital expenditures -286.43K, giving a free cash flow of -78.87M billion.
Operating Cash Flow-78.58M
Free Cash Flow-78.87M
Free Cash Flow per Share-0.04
Dividends & Yields
Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change-62.86%
50-Day Moving Average0.14
200-Day Moving Average0.30
Relative Strength Index (RSI)39.49
Average Volume (3m)8.47M
Important Dates
Botanix Pharmaceuticals Limited upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Botanix Pharmaceuticals Limited as a current ratio of 4.00, with Debt / Equity ratio of 1.50%
Current Ratio4.00
Quick Ratio2.87
Debt to Market Cap0.05
Net Debt to EBITDA0.79
Interest Coverage Ratio-15.05
Taxes
In the past 12 months, Botanix Pharmaceuticals Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Botanix Pharmaceuticals Limited EV to EBITDA ratio is -6.53, with an EV/FCF ratio of -6.68.
EV to Sales90.97
EV to EBITDA-6.53
EV to Free Cash Flow-6.68
EV to Operating Cash Flow-6.70
Balance Sheet
Botanix Pharmaceuticals Limited has AU$64.97M in cash and marketable securities with AU$1.22M in debt, giving a net cash position of AU$63.75M billion.
Cash & Marketable SecuritiesAU$64.97M
Total DebtAU$1.22M
Net CashAU$63.75M
Net Cash Per ShareAU$0.03
Tangible Book Value Per ShareAU$0.03
Margins
Gross margin is 34.85%, with operating margin of -1395.62%, and net profit margin of -1492.37%.
Gross Margin34.85%
Operating Margin-1395.62%
Pretax Margin-1492.37%
Net Profit Margin-1492.37%
EBITDA Margin-1393.13%
EBIT Margin-1432.23%
Analyst Forecast
The average price target for Botanix Pharmaceuticals Limited is AU$1.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$1.14
Price Target Upside714.29% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast456.50%
EPS Growth Forecast-457.14%